Author | Michael Postow, MD | OncLive

Author | Michael Postow, MD

Articles

Dr. Postow on OS Results of CheckMate-069 Study

April 18, 2016

Video

Michael Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the overall survival (OS) results of the CheckMate-069 study, which investigated the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the treatment of patients with melanoma.

Dr. Postow on Nivolumab Combined With Ipilimumab in Melanoma

March 31, 2016

Video

Michael Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the treatment of patients with melanoma.

x